-
December 23, 2011
EU OKs Roche's Avastin for ovarian cancer
ZURICH (Reuters) - The European Commission has approved Roche's drug Avastin for treating women with newly diagnosed, advanced ovarian cancer, offering new options to sufferers previously limited to surgery and chemotherapy.
-
November 29, 2011
Better ovarian cancer screening, still no answers
NEW YORK (Reuters Health) - After disappointing results earlier this year, researchers say new study findings from Kentucky offer a bit of hope for ovarian cancer screening.
-
August 8, 2011
Scientists find new ovarian cancer gene
LONDON (Reuters) - Women who carry a faulty copy of a gene called RAD51D have an almost one in 11 chance of developing ovarian cancer, scientists said on Sunday in a finding they called the most significant ovarian cancer gene discovery for more than 10 years.
-
June 7, 2011
CORRECTION: Ovarian cancer screening doesn't save lives: study
NEW YORK (Reuters Health) - Women screened annually for ovarian cancer were just as likely to die from the disease as women who didn't have regular screening, concludes a large new study that found screening did not catch the cancers earlier as it is intended to do.
-
June 6, 2011
Ovarian cancer screening doesn't save lives: study
NEW YORK (Reuters Health) - Women screened annually for ovarian cancer were just as likely to die from the disease as women who didn't have regular screening, concludes a large new study that found screening did not catch the cancers earlier as it is intended to do.
-
May 26, 2011
Roche upbeat on Avastin in ovarian cancer
ZURICH (Reuters) - Roche Holding AG, the world's leader in oncology drugs, struck an upbeat tone about approval prospects for its key drug Avastin in ovarian cancer ahead of an important industry meeting next month.
-
May 4, 2011
CORRECTION: Finding ovarian cancer fast may not help survival
NEW YORK (Reuters Health) - Once a woman begins experiencing symptoms of ovarian cancer, getting diagnosed and treated quickly may not help her survive longer, according to a new study of Australian women.
-
May 3, 2011
Finding ovarian cancer fast may not help survival
NEW YORK (Reuters Health) - Once a woman begins experiencing symptoms of ovarian cancer, getting diagnosed and treated quickly may not help her survive longer, according to a new study of Australian women.
-
February 8, 2011
Avastin helps stabilize recurrent ovarian cancer
ZURICH (Reuters) - Roche's top-selling drug Avastin helps women with recurrent ovarian cancer live significantly longer without their disease getting worse, a late-stage trial showed, giving the troubled drug a much needed boost.
-
December 23, 2010
Do all contraceptives lower ovarian cancer risk?
NEW YORK (Reuters Health) - Birth control pills have long been known to reduce the risk of ovarian cancer, but a new study suggests any type of contraceptive - even, surprisingly, vasectomy - may also be protective.
-
October 11, 2010
Avastin helps in ovarian cancer but effects fade
MILAN (Reuters) - Roche's blockbuster drug Avastin helps women with ovarian cancer live longer without their disease getting worse, but its effect peaks at 12 months and then diminishes, researchers said on Monday.
-
September 20, 2010
Gene studies zero in on breast, ovarian cancer risk
LONDON (Reuters) - Scientists have found a region of DNA that can increase or decrease the high chance of breast cancer linked to a particular gene variant - a finding that could help doctors keep a closer eye on women most at risk.
-
September 9, 2010
Two gene mutations mark deadly ovarian cancer
WASHINGTON (Reuters) - Researchers have identified two new genetic mutations that cause a significant number of the hardest-to-treat kinds of ovarian cancer, and say they point to a new "on-off" switch for tumors.
-
December 31, 2009
Proteins show promise for ovarian cancer screening
WASHINGTON (Reuters) - Elevated levels of three proteins show ovarian cancer is starting to grow years before women are diagnosed, but they do not increase soon enough to be an early indicator of the disease, U.S. researchers said on Wednesday.
-
July 30, 2009
Nanotech gene therapy kills ovarian cancer in mice
CHICAGO (Reuters) - Tiny synthetic particles carrying a payload of toxin worked as well as chemotherapy at killing ovarian cancer cells in mice, without the bad side effects, U.S. researchers said on Thursday.
-
July 24, 2009
Early periods may reduce ovarian cancer survival
NEW YORK (Reuters Health) - Women whose menstrual periods start at a young age are less likely to survive ovarian cancer than their peers whose periods start later, new research shows. Similarly, women who have more menstrual cycles over their lifetime also have worse survival.
-
July 14, 2009
Hormone replacement therapy tied to ovarian cancer
NEW YORK (Reuters Health) - New research suggests that no matter how hormone replacement therapy is given, it increases the risk of ovarian cancer.
-
April 22, 2009
Plant-based flavonoid may cut ovarian cancer risk
NEW YORK (Reuters Health) - Women who eat greater amounts of plant-based foods and drinks with the naturally occurring flavonoid, apigenin, may have a decreased risk for ovarian cancer, study findings suggest.
-
March 31, 2009
Screening misses early ovarian cancer
NEW YORK (Reuters Health) - Annual screening with ultrasound and a blood test called CA 125 usually misses early cases of ovarian cancer, according to a report in the journal Obstetrics and Gynecology. In addition, ovarian cancer screening often leads to unnecessary biopsies and other surgical procedures.
-
March 11, 2009
Blood, ultrasound tests catch ovarian cancer: study
WASHINGTON (Reuters) - Blood tests and ultrasound scans can catch deadly ovarian cancer at the most early and treatable stages, British doctors reported on Tuesday, saying it may finally be possible to screen women for the disease.
-
December 15, 2008
Possible way to treat ovarian cancer reported
NEW YORK (Reuters Health) - Blocking certain proteins in cells may be a way to attack ovarian cancer, researchers said at the annual meeting of the American Society for Cell Biology underway in San Francisco.
-
August 22, 2008
Plant-based flavonoids may cut ovarian cancer risk
NEW YORK (Reuters Health) - High consumption of two types of flavonoids -- antioxidant chemicals found in plant foods -- may help protect women from ovarian cancer, research from Italy suggests.
-
July 17, 2008
Analgesic drugs don't reduce ovarian cancer risk
NEW YORK (Reuters Health) - The regular use of over-the-counter analgesic drugs, such as aspirin and ibuprofen, does not appear to reduce the risk of ovarian cancer, according to findings published in the American Journal of Epidemiology.
-
March 20, 2008
Ovarian cancer risk lower with longer time on Pill
NEW YORK (Reuters Health) - For each year that a woman takes an oral contraceptive, her risk of ovarian cancer is reduced by about 5 percent on average, report investigators from the University of Hawaii.
-
March 18, 2008
Ovarian cancer risk seen in DES grand-daughters
NEW YORK (Reuters Health) - Women whose mothers were exposed to diethylstilbestrol (DES) in the womb appear to be at increased risk of developing ovarian cancer, researchers report in the journal Epidemiology.
-
February 15, 2008
Blood test detects ovarian cancer early
NEW YORK (Reuters Health) - Researchers have developed what they believe is the first blood test that accurately detects ovarian cancer at an early stage.
-
January 25, 2008
Birth control pill lowers ovarian cancer risk - study
LONDON (Reuters) - Birth control pills can protect women against ovarian cancer for 30 years or longer after they stop taking them and have so far prevented 100,000 ovarian cancer deaths worldwide, British researchers said on Thursday.
-
January 22, 2008
Drinking coffee may lower ovarian cancer risk: study
LONDON (Reuters) - Caffeine appears to lower a woman's chances of developing ovarian cancer, U.S. researchers said on Tuesday, while smoking cigarettes and drinking alcohol do not.
-
January 2, 2008
Chronic inflammation not linked to ovarian cancer
NEW YORK (Reuters Health) - The results of a study published in the International Journal of Cancer suggest that most factors that may cause inflammation of the ovaries are not associated with a statistically significant increased risk of ovarian cancer.
-
December 26, 2007
Ultrasound fails to spot early ovarian cancer
NEW YORK (Reuters Health) - Annual screening with a technique called transvaginal ultrasound, coupled with a blood test for CA125, a protein that can be elevated in the setting of ovarian cancer, does not reliably detect ovarian cancer early, at a more curable stage, according to a new study.
-
December 24, 2007
Tea drinking may not curb ovarian cancer risk
NEW YORK (Reuters Health) - Tea drinking, in general, does not appear to decrease the risk for ovarian cancer, according to combined data from nine studies.
-
October 9, 2007
Low-fat diet may lower ovarian cancer risk
NEW YORK (Reuters Health) - Long-term adherence to a low-fat diet may reduce the risk of ovarian cancer, according to the results of the Women's Health Initiative Dietary Modification trial, which involved nearly 50,000 postmenopausal women.
-
July 25, 2007
Fertility may be preserved after ovarian cancer
NEW YORK (Reuters Health) - Women with malignant ovarian germ cell tumors who undergo surgery intended to preserve fertility plus platinum-based chemotherapy are very likely to retain menstrual function and fertility, findings from a new study indicate.
-
April 9, 2007
Ovarian cancer treatment sub par in many women
NEW YORK (Reuters Health) - A large number of women with ovarian cancer in the US -- perhaps as many as 1 in 3 -- are not receiving appropriate surgical treatment, hints a review of 10,432 women with the disease.
-
March 9, 2007
Low-dose 'Pill' reduces ovarian cancer risk
NEW YORK (Reuters Health) - Oral contraceptives with low levels of estrogen and progestin reduce the risk of ovarian cancer even more than older versions of the 'Pill', according to investigators at the University of Hawaii in Honolulu.